| Application no. and date | 15753700.2 (espacenet) (Federated) (European Patent Register), 20150825 | | Patent/reg. no. and date | DK/EP 3186283, 20191225 | | Publication date | 20170705 | | Priority no. and date | EP 14182778, 20140829 | | EP pub. no. and date |
EP 3186283 20170705 | | Effective date | | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Base, CH | | Applicant ref. no. | P71206DK01 | | Inventor | KLEIN, Christian, Chruezacherweg 41
CH-8906 Bonstetten, CH,
UMANA, Pablo, Felsenrainstrasse 28
CH-8832 Wollerau, CH,
NICOLINI, Valeria G., Sandfelsenstrasse 4
CH-8703 Erlenbach/ZH, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 47/50 (2017.01) , A61P 35/00 (2006.01) , C07K 14/55 (2006.01) , C07K 16/28 (2006.01) , C07K 16/30 (2006.01) , C07K 16/40 (2006.01) | | Title | Kombinationsbehandling med tumormålrettede IL-2- immuncytokinervarianter og antistoffer mod humant PD-L1 | | Int. application no. | EP2015069399 | | Int. publication no. | WO2016030350 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
